SGTL2 inhibitors and amputations in the US FDA Adverse Event Reporting System

LANCET DIABETES & ENDOCRINOLOGY

ELSEVIER SCIENCE INC

1. University of Padova (Padova, Italy)
2. AstraZeneca
3. Eli Lilly
4. Boehringer Ingelheim
5. Novo Nordisk
6. Sanofi
7. Abbott
8. Novartis
9. Merck Sharp Dohme
10. Mediolanum
11. Servier
12. Janssen
13. Merck Sharp Dome
14. Lilly
15. Takeda